Last reviewed · How we verify

NCT06765512

Artificial Intelligence-Based Machine Learning to Diagnose and Classify Adenomyosis from Ultrasound Scans: a Multicentre Model Development Study

Active, enrolled Last updated 9 January 2025
What this trial tests

trial testing use of deep learning and automated machine learning to diagnose and classify adenomyosis in Adenomyosis of Uterus in 10,000 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
4 June 2024
Primary endpoint
4 December 2025
6 February 2026

Quick facts

Lead sponsorCARE Fertility UK
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment10,000
Start date4 June 2024
Primary completion4 December 2025
Estimated completion6 February 2026
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

CARE Fertility UK

Who can join

Eligibility, female only, with Adenomyosis of Uterus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to use the vast dataset of annotated ultrasound images of normal uterus and of adenomyosis of varying severity to train a neural network using deep learning framework (Pytorch) and automated machine learning tool (Vertex AI). The main question it aims to answer are: 1. Diagnostic performance of automated (Google Vertex AI (Artificial intelligence) vision) and deep learning (Pytorch) machine learning model 2. Time saved in assessment of adenomyosis per healthcare professional

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Adenomyosis of Uterus

Currently open trials in the same condition.

Other CARE Fertility UK trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06765512.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing